ArticleJournal of skin cancer2026

Real-World Outcomes of Immune Checkpoint Inhibitors in Melanoma, Including Acral and Mucosal Subtypes: A Retrospective Cohort Study From a Latin American Center.

Vaneza Avila-Rodriguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.